Healthcare Stock Comparison

Compare the best healthcare stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 7 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
PFEPfizer
$33.69
0.2 (0.6%)
$40.13
(19.12% Upside)
187.26B
19.60
5.58%
2Buy
7Hold
0Sell
0
Hold
NVSNovartis
$87.45
1.54 (1.79%)
$103.80
(18.70% Upside)
197.36B
24.80
1.20%
2Buy
1Hold
1Sell
0
Moderate Buy
MRKMerck & Company
$72.38
-0.24 (-0.33%)
$93.50
(29.18% Upside)
183.12B
26.20
-7.91%
3Buy
1Hold
0Sell
0
Strong Buy
JNJJohnson & Johnson
$159.32
0.86 (0.54%)
$189.90
(19.19% Upside)
418.80B
28.80
16.23%
10Buy
1Hold
0Sell
0
Strong Buy
RHHBYRoche Holding
$40.97
-0.13 (-0.32%)
279.62B
17.80
1.71%
1Buy
1Hold
0Sell
0
Moderate Buy

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Healthcare Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Healthcare Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
MRKMerck & Company
Buy
Reiterated
PFEPfizer Inc
Hold
Reiterated
JNJJohnson & Johnson
Hold
Reiterated
NVSNovartis AG
Hold
Downgraded
RHHBYRoche Holding AG
Hold
Downgraded
MRKMerck & Company
Hold
Reiterated
PFEPfizer Inc
Hold
Reiterated
PFEPfizer Inc
Buy
Upgraded
PFEPfizer Inc
Buy
Reiterated
PFEPfizer Inc
Hold
Reiterated

Most Recent Earnings of Healthcare Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
PFEPfizer
Feb 02, 2021
2020 (Q4)
0.54 / 0.10
-0.061
263.93% (+0.16)
NVSNovartis
Jan 26, 2021
2020 (Q4)
1.38 / 0.93
0.499
85.77% (+0.43)
MRKMerck & Company
Feb 04, 2021
2020 (Q4)
1.38 / -0.82
0.921
-189.47% (-1.75)
JNJJohnson & Johnson
Jan 26, 2021
2020 (Q4)
1.83 / 0.65
1.502
-56.66% (-0.85)
RHHBYRoche Holding
Feb 04, 2021
2020 (Q4)
1.24 / 1.00
0.721
38.14% (+0.28)

Healthcare Stocks - FAQ

Which Healthcare stocks have a "Strong Buy" analyst rating?
These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:
Merck & Company - Strong Buy, based on 4 analyst ratings, 3 Buy, 1 Hold, and 0 Sell.
Johnson & Johnson - Strong Buy, based on 11 analyst ratings, 10 Buy, 1 Hold, and 0 Sell.
Are Healthcare stocks overpriced?
Pfizer's stock price is currently $33.69, and its average 12-month price target is $40.13.
Novartis's stock price is currently $87.45, and its average 12-month price target is $103.80.
Merck & Company's stock price is currently $72.38, and its average 12-month price target is $93.50.
Johnson & Johnson's stock price is currently $159.32, and its average 12-month price target is $189.90.
Roche Holding's stock price is currently $40.97, and its average 12-month price target is N/A.
Which Healthcare stocks pay dividends?
Pfizer does not currently pay dividends.
Novartis currently pays a dividend of $2.20 which represents an annual dividend yield of 3.93%. Novartis's next Ex-dividend date is March 4, 2021 and its next payout date is March 15, 2021.
Merck & Company currently pays a dividend of $0.65 which represents an annual dividend yield of 3.58%. Merck & Company's next Ex-dividend date is March 12, 2021 and its next payout date is April 7, 2021.
Johnson & Johnson does not currently pay dividends.
Roche Holding currently pays a dividend of $0.81 which represents an annual dividend yield of 1.97%. Roche Holding's next Ex-dividend date is March 18, 2021 and its next payout date is March 29, 2021.